Galapagos NV
GLPG
#5074
Rank
A$2.66 B
Marketcap
A$39.61
Share price
0.00%
Change (1 day)
-20.20%
Change (1 year)

Earnings for Galapagos NV (GLPG)

Earnings in 2026 (TTM): A$0.81 Billion

According to Galapagos NV's latest financial reports the company's current earnings are A$1.22 Billion. In 2025 the company made an earning of A$0.52 Billion, an increase over its 2024 earnings that were of -A$8.26 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Galapagos NV from 2015 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) A$0.81 B55.42%
2025 A$0.52 B-6464.81%
2024 -A$8.26 Million-82.77%
2023 -A$47.92 Million-85.59%
2022 -A$0.34 Billion60.71%
2021 -A$0.21 Billion-60.08%
2020 -A$0.52 Billion-331.44%
2019 A$0.22 B-523.76%
2018 -A$52.86 Million-72.34%
2017 -A$0.2 Billion-329.59%
2016 A$83.24 M-144.3%
2015 -A$0.19 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
A$37.11 B 4,596.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
A$11.62 B 1,371.11%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
A$8.53 B 980.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
A$10.94 B 1,284.59%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
A$18.78 B 2,277.78%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
A$20.94 B 2,551.14%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
A$14.30 B 1,709.98%๐Ÿ‡ฌ๐Ÿ‡ง UK
Fortress Biotech
FBIO
A$0.19 B-75.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
A$3.24 B 310.58%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel